PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A systematic review and meta-analysis of clinical studies assessed the potential impact of Abelmoschus esculentus on lipid parameters [PMID:39456704]
A systematic review and meta-analysis of randomized controlled trials examined the effects of okra consumption on cardiometabolic risk factors [PMID:39726865]
Review indicates that while in vivo and in vitro studies show ability to overcome symptoms, there is a notable lack of clinical studies [PMID:32222004]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 32222004 (2020) — Effect of Abelmoschus esculentus (okra) on metabolic syndrome: A review. · Phytotherapy research : PTR
- 2.PMID: 39456704 (2024) — Effect of Abelmoschus esculentus L. (Okra) on Dyslipidemia: Systematic Review and Meta-Analysis of Clinical Studies. · International journal of molecular sciences
- 3.PMID: 35037792 (2023) — Biological activity and development of functional foods fortified with okra (Abelmoschus esculentus). · Critical reviews in food science and nutrition
- 4.PMID: 33525745 (2021) — Okra (Abelmoschus Esculentus) as a Potential Dietary Medicine with Nutraceutical Importance for Sustainable Health Applications. · Molecules (Basel, Switzerland)
- 5.PMID: 35963420 (2022)